Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers

European Heart Journal Cardiovascular Imaging

Volumn 14, Issue 7, 2013, Pages 650-658

  Bates, Matthew G D ^a,b   Hollingsworth, Kieren G ^a   Newman, Jane H ^a   Jakovljevic, Djordje G ^a   Blamire, Andrew M ^a   MacGowan, Guy A ^a,b   Keavney, Bernard D ^a,b   Chinnery, Patrick F ^a   Turnbull, Douglass M ^a   Taylor, Robert W ^a   Trenell, Michael I ^a   Gorman, Grainne S ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Cardiac tagging; Cardiomyopathy; Magnetic resonance imaging; Magnetic resonance spectroscopy; Mitochondrial disease

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE KINASE; GADOLINIUM; MITOCHONDRIAL DNA;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; CONCENTRIC HYPERTROPHIC REMODELLING; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; CORRELATIONAL STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; GENE MUTATION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE MASS; HEART VENTRICLE HYPERTROPHY; HETEROZYGOTE; HUMAN; MALE; MORTALITY; POINT MUTATION; PRIORITY JOURNAL; SUBENDOCARDIAL DYSFUNCTION; SYSTOLIC DYSFUNCTION; TORSION;

CARDIAC TAGGING; CARDIOMYOPATHY; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MITOCHONDRIAL DISEASE;

ADULT; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; COHORT STUDIES; CONTRAST MEDIA; DNA, MITOCHONDRIAL; FEMALE; GADOLINIUM DTPA; HETEROZYGOTE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING, CINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MITOCHONDRIAL DISEASES; POINT MUTATION; PROGNOSIS; REFERENCE VALUES; STATISTICS, NONPARAMETRIC; VENTRICULAR REMODELING;

EID: 84879223347     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes226     Document Type: Article

References (35)

1. Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet 2008;83:254-60.
2. Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol 1994;9:4-13. (Pubitemid 24022131)
3. Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M et al. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation 1995;91:955-61.
4. Majamaa-Voltti K, Peuhkurinen K, Kortelainen ML, Hassinen IE, Majamaa K. Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A . G. BMC Cardiovasc Disord 2002;2:12.
5. Holmgren D, Wahlander H, Eriksson B, Oldfors A, Holme E, Tulinius M. Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur Heart J 2003;24:280-8. (Pubitemid 36207084)
6. Vydt TCG, de Coo RFM, Soliman OII, Ten Cate FJ, van Geuns R-JM, Vletter WB et al. Cardiac involvement in adults with m.3243A . G MELAS gene mutation. Am J Cardiol 2007;99:264-9. (Pubitemid 46072766)
7. Majamaa-Voltti K, Turkka J, Kortelainen ML, Huikuri H, Majamaa K. Causes of death in pedigrees with the 3243A . G mutation in mitochondrial DNA. J Neurol Neurosurg Psychiatry 2008;79:209-11. (Pubitemid 351236560)
8. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:e1-90.
9. Duboc D, Meune C, Lerebours G, Devaux JY, Vaksmann G, Becane HM. Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy. J Am Coll Cardiol 2005;45:855-7. (Pubitemid 40342808)
10. Myerson SG, Montgomery HE, World MJ, Pennell DJ. Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension 2002;40:673-8. (Pubitemid 35278604)
11. Yilmaz A, Gdynia HJ, Baccouche H, Mahrholdt H, Meinhardt G, Basso C et al. Cardiac involvement in patients with Becker muscular dystrophy: new diagnostic and pathophysiological insights by a CMR approach. J Cardiovasc Magn Reson 2008; 10:50.
12. Pfeffer G, Majamaa K, Turnbull DM, Thorburn D, Chinnery PF. Treatment for mitochondrial disorders. Cochrane Database Syst Rev 2012;4:CD004426.
13. Lumens J, Delhaas T, Arts T, Cowan BR, Young AA. Impaired subendocardial contractile myofiber function in asymptomatic aged humans, as detected using MRI. Am J Physiol Heart Circ Physiol 2006;291:H1573-9. (Pubitemid 44497660)
14. Van Der Toorn A, Barenbrug P, Snoep G, Van Der Veen FH, Delhaas T, Prinzen FW et al. Transmural gradients of cardiac myofiber shortening in aortic valve stenosis patients using MRI tagging. Am J Physiol Heart Circ Physiol 2002; 283:H1609-15.
15. Young AA, Kramer CM, Ferrari VA, Axel L, Reichek N. Three-dimensional left ventricular deformation in hypertrophic cardiomyopathy. Circulation 1994;90: 854-67. (Pubitemid 24242755)
16. Russel IK, Brouwer WP, Germans T, Knaapen P, Marcus JT, van der Velden J et al. Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness. J Cardiovasc Magn Reson 2011;13:3.
17. Crilley JG, Boehm EA, Blair E, Rajagopalan B, Blamire AM, Styles P et al. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 2003;41:1776-82. (Pubitemid 36584252)
18. Neubauer S, Krahe T, Schindler R, Horn M, Hillenbrand H, Entzeroth C et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992;86:1810-8.
19. Lodi R, Rajagopalan B, Blamire AM, Crilley JG, Styles P, Chinnery PF. Abnormal cardiac energetics in patients carrying the A3243G mtDNA mutation measured in vivo using phosphorus MR spectroscopy. Biochimica et Biophysica Acta 2004; 1657:146-50. (Pubitemid 38952875)
20. Schaefer AM, Phoenix C, Elson JL, McFarland R, Chinnery PF, Turnbull DM. Mitochondrial disease in adults: a scale to monitor progression and treatment. Neurology 2006;66:1932-4. (Pubitemid 44049832)
21. Whittaker RG, Blackwood JK, Alston CL, Blakely EL, Elson JL, McFarland R et al. Urine heteroplasmy is the best predictor of clinical outcome in the m.3243A . G mtDNA mutation. Neurology 2009;72:568-9.
22. Schar M, Vonken EJ, Stuber M. Simultaneous B(0)-and B(1)+map acquisition for fast localized shim, frequency, and RF power determination in the heart at 3 T. Magn Reson Med 2010;63:419-26.
23. Vanhamme L, Van Huffel S, Van Hecke P, van Ormondt D. Time-domain quantification of series of biomedical magnetic resonance spectroscopy signals. J Magn Reson 1999;140:120-30. (Pubitemid 129609621)
24. Jones DE, Hollingsworth K, Fattakhova G, MacGowan G, Taylor R, Blamire A et al. Impaired cardiovascular function in primary biliary cirrhosis. Am J Physiol Gastrointest Liver Physiol 2010;298:G764-73.
25. Cheng S, Fernandes VR, Bluemke DA, McClelland RL, Kronmal RA, Lima JA. Age-related left ventricular remodeling and associated risk for cardiovascular outcomes: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging 2009;2: 191-8.
26. Hundley WG, Bluemke D, Bogaert JG, Friedrich MG, Higgins CB, Lawson MA et al. Society for cardiovascular magnetic resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson 2009;11:5.
27. Alfakih K, Plein S, Thiele H, Jones T, Ridgway JP, Sivananthan MU. Normal human left and right ventricular dimensions for MRI as assessed by turbo gradient echo and steady-state free precession imaging sequences. J Magn Reson Imaging 2003; 17:323-9. (Pubitemid 36259246)
28. Fonseca CG, Dissanayake AM, Doughty RN, Whalley GA, Gamble GD, Cowan BR et al. Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction. Am J Cardiol 2004;94:1391-5. (Pubitemid 39556208)
29. Hor KN, Wansapura J, Markham LW, Mazur W, Cripe LH, Fleck R et al. Circumferential strain analysis identifies strata of cardiomyopathy in Duchenne muscular dystrophy: a cardiac magnetic resonance tagging study. J Am Coll Cardiol 2009;53: 1204-10.
30. Kang SJ, Lim HS, Choi BJ, Choi SY, Hwang GS, Yoon MH et al. Longitudinal strain and torsion assessed by two-dimensional speckle tracking correlate with the serum level of tissue inhibitor of matrix metalloproteinase-1, a marker of myocardial fibrosis, in patients with hypertension. J Am Soc Echocardiogr 2008; 21:907-11.
31. Chung J, Abraszewski P, Yu X, Liu W, Krainik AJ, Ashford M et al. Paradoxical increase in ventricular torsion and systolic torsion rate in type I diabetic patients under tight glycemic control. J Am Coll Cardiol 2006;47:384-90. (Pubitemid 43063259)
32. Maassen JA, LM TH, Van Essen E, Heine RJ, Nijpels G, Jahangir Tafrechi RS et al. Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 2004;53:S103-9. (Pubitemid 38168701)
33. Schwartzkopff B, Mundhenke M, Strauer BE. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia. J Am Coll Cardiol 1998;31:1089-96. (Pubitemid 28212511)
34. Arts T, Reneman RS, Veenstra PC. A model of the mechanics of the left ventricle. Ann Biomed Eng 1979;7:299-318. (Pubitemid 10109942)
35. Lodi R, Rajagopalan B, Blamire AM, Cooper JM, Davies CH, Bradley JL et al. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study. Cardiovasc Res 2001;52:111-9 (Pubitemid 32835244)